IP Library Granted Patent US 9,346,917
Granted Patent B2
US 9,346,917 · App. 14/467,634 · Granted May 24, 2016

Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

Inventor: Antoni Kozlowski (Huntsville, AL)
Assignee: Nektar Therapeutics
C08G65/48A61K47/48215A61K47/48776
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,346,917
App. No.
14/467,634
Granted
May 24, 2016
Kind
B2
Abstract

The invention provides for preparing a polymer-active agent conjugate, the method comprising the steps of reacting an amino acid derivative with a biologically active agent under conditions to form a polymer-active agent conjugate.

Claims (12)

1. A water-soluble and non-peptidic polymer having the following structure

wherein:

POLY a and POLY b are each a water-soluble and non-peptidic polymer R is a central core molecule;

q is an integer from 2 to about 300; and

each X is a capping group.

2. The water-soluble and non-peptidic polymer of claim 1 , wherein each of POLY a and POLY b is the same.

3. The water-soluble and non-peptidic polymer of claim 2 , wherein each of POLY a and POLY b is a poly(ethylene glycol).

4. The water-soluble and non-peptidic polymer of claim 3 , wherein each of POLY a and POLY b has an average molecular weight from about 200 Da to about 100,000 Da.

5. The water-soluble and non-peptidic polymer of claim 1 , wherein each of POLY a and POLY b is different.

6. The water-soluble and non-peptidic polymer of claim 1 , wherein R is glycerol.

7. The water-soluble and non-peptidic polymer of claim 1 , wherein R is penaerythritol.

8. The water-soluble and non-peptidic polymer of claim 1 , wherein each X is independently selected from the group consisting of alkoxy, hydroxyl, protected hydroxyl, active ester, active carbonate, acetal, aldehyde, aldehyde hydrates, alkenyl, acrylate, methacrylate, acrylamide, active sulfone, protected amine, protected hydrazide, thiol, protected thiol, carboxylic acid, protected carboxylic acid, isocyanate, isothiocyanate, maleimide, vinylsulfone, dithiopyridine, vinylpyridine, iodoacetamide, epoxide, glyoxal, dione, mesylate, tosylate, and tresylate.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 33760, FRAME 0791 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036865/0265 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
SECURITY INTEREST Recorded Sep 17, 2014
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 033760/0791 →
Continuity (12)
Continuation 14059020 · Oct 21, 2013
Continuation 13664021 · Oct 30, 2012
Continuation 13154917 · Jun 7, 2011
Continuation 12756905 · Apr 8, 2010
Continuation 12433874 · Apr 30, 2009
Continuation 12150136 · Apr 25, 2008
Continuation 11492133 · Jul 24, 2006
Continuation 10727337 · Dec 2, 2003
Continuation 10068371 · Feb 6, 2002
Division 09740556 · Dec 18, 2000
Provisional Application 60171834 · Dec 22, 1999
Related Publication 20150191568A1 · Jul 9, 2015